ȸ»ç¼Ò°³
Á¦Ç°¼Ò°³
>
ÀÚ·á½Ç
°í°´¼¾ÅÍ
Home
>
ÀÚ·á½Ç
ÀÚ·á½Ç
41
¶óÀ̽ºÁ¤¿¡ ´ëÇÑ ÇÁ·¹Á¨Å×À̼ÇÀÚ·á ÀÔ´Ï´Ù.(4)
(ÁÖ)½Å¿µ
2011.01.13
14928
40
¶óÀ̽ºÁ¤¿¡ ´ëÇÑ ÇÁ·¹Á¨Å×À̼ÇÀÚ·á ÀÔ´Ï´Ù.(1)
(ÁÖ)½Å¿µ
2011.01.10
14831
39
¶óÀ̽ºÁ¤ ÀÓ»óÀÚ·á ¸®½ºÆ®ÀÔ´Ï´Ù.(Study Design)
(ÁÖ)½Å¿µ
2011.01.13
14556
38
¶óÀ̽ºÁ¤ ÀÓ»óÀÚ·á ¸®½ºÆ®ÀÔ´Ï´Ù.(Results)
(ÁÖ)½Å¿µ
2011.01.13
14362
37
¶óÀ̽ºÁ¤¿¡ ´ëÇÑ ÇÁ·¹Á¨Å×À̼ÇÀÚ·á ÀÔ´Ï´Ù.(3)
(ÁÖ)½Å¿µ
2011.01.13
14220
36
¶óÀ̽ºÁ¤¿¡ ´ëÇÑ ÇÁ·¹Á¨Å×À̼ÇÀÚ·á ÀÔ´Ï´Ù.(6)
(ÁÖ)½Å¿µ
2011.01.13
14201
35
¶óÀ̽ºÁ¤¿¡ ´ëÇÑ ÇÁ·¹Á¨Å×À̼ÇÀÚ·á ÀÔ´Ï´Ù.(5)
(ÁÖ)½Å¿µ
2011.01.13
14164
34
¶óÀ̽ºÁ¤¿¡ ´ëÇÑ ÇÁ·¹Á¨Å×À̼ÇÀÚ·á ÀÔ´Ï´Ù.(2)
(ÁÖ)½Å¿µ
2011.01.13
14105
33
34-Marogna_Colombo_Clinical_efficacy_of_a_sublingu..
(ÁÖ)½Å¿µ
2011.01.10
13674
32
Bagnasco,Pharmacokineticsofanallergenandamonomeric..
(ÁÖ)½Å¿µ
2012.04.03
13291
31
PassaliSafetyandtolerability
(ÁÖ)½Å¿µ
2012.04.03
13268
30
04-quercia
(ÁÖ)½Å¿µ
2012.04.03
13163
1
[2]
[3]
[4]